Evidence map›Paper›PMID 31209204›Full record

ArticleCell death & disease2019

Perturbation of synapsins homeostasis through HIV-1 Tat-mediated suppression of BAG3 in primary neuronal cells.

Taha Mohseni Ahooyi, Bahareh Torkzaban, Masoud Shekarabi, Farzaneh G Tahrir, Emilie A Decoppet, Bianca Cotto, Dianne Langford, Shohreh Amini, Kamel Khalili

Open access · goldAbstract read
In one paragraph

Article in Cell death & disease, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.5field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Taha Mohseni AhooyiDepartment of Neuroscience Center for Neurovirology, Lewis Katz School of Medicine at Temple University, 3500N. Broad Street, Philadelphia, PA, 19140, USA. taha.mohseni.ahooyi@temple.edu.
Bahareh TorkzabanDepartment of Neuroscience Center for Neurovirology, Lewis Katz School of Medicine at Temple University, 3500N. Broad Street, Philadelphia, PA, 19140, USA.
Masoud ShekarabiDepartment of Neuroscience Center for Neurovirology, Lewis Katz School of Medicine at Temple University, 3500N. Broad Street, Philadelphia, PA, 19140, USA.
Farzaneh G TahrirDepartment of Neuroscience Center for Neurovirology, Lewis Katz School of Medicine at Temple University, 3500N. Broad Street, Philadelphia, PA, 19140, USA.
Emilie A DecoppetDepartment of Neuroscience Center for Neurovirology, Lewis Katz School of Medicine at Temple University, 3500N. Broad Street, Philadelphia, PA, 19140, USA.
Bianca CottoDepartment of Neuroscience Center for Neurovirology, Lewis Katz School of Medicine at Temple University, 3500N. Broad Street, Philadelphia, PA, 19140, USA.
Dianne LangfordDepartment of Neuroscience Center for Neurovirology, Lewis Katz School of Medicine at Temple University, 3500N. Broad Street, Philadelphia, PA, 19140, USA.
Shohreh AminiDepartment of Neuroscience Center for Neurovirology, Lewis Katz School of Medicine at Temple University, 3500N. Broad Street, Philadelphia, PA, 19140, USA.
Kamel KhaliliDepartment of Neuroscience Center for Neurovirology, Lewis Katz School of Medicine at Temple University, 3500N. Broad Street, Philadelphia, PA, 19140, USA. kamel.khalili@temple.edu.
Temple University · US

Funding

Viral Gene Editing and Bioinformatics Core for Institution # 269291P30MH092177 · NIMH · TEMPLE UNIV OF THE COMMONWEALTH · PI Kamel Khalili · 2011 to 2026
$24.9M
Project 3 Dysregulation of metabolic communication of oligodendrocytes and neurons by cocaine and TatP01DA037830 · NIDA · TEMPLE UNIV OF THE COMMONWEALTH · PI KHALILI, KAMEL · 2015 to 2019
$7.4M
Interdisciplinary And Translational Research Training In NeurohivT32MH079785 · NIMH · TEMPLE UNIV OF THE COMMONWEALTH · PI Kamel Khalili · 2008 to 2026
$5.4M
Involvement of BAG3 in HIV-1 induced cardiomyopathyR01HL123093 · NHLBI · TEMPLE UNIV OF THE COMMONWEALTH · PI CHEUNG, JOSEPH Y, FELDMAN, ARTHUR M · 2014 to 2018
$3.7M
HIV modulation of BAG3 impacting quality control of Tau in neuronal cellsR01AG060962 · NIA · TEMPLE UNIV OF THE COMMONWEALTH · PI KHALILI, KAMEL · 2018 to 2022
$2.0M
PINCH-mediated CNS cell dysfunction and tauopathy in HIVR01MH107340 · NIMH · TEMPLE UNIV OF THE COMMONWEALTH · PI LANGFORD, DIANNE TERESA · 2016 to 2020
$2.0M
NHLBI NIH HHS R01 HL123093NIA NIH HHS R01 AG060962NIDA NIH HHS P01 DA037830NIMH NIH HHS P30 MH092177NIMH NIH HHS R01 MH107340NIMH NIH HHS T32 MH079785
6 · The paper itself

Abstract

HIV-1 Tat is known to be released by HIV infected non-neuronal cells in the brain, and after entering neurons, compromises brain homeostasis by impairing pro-survival pathways, thus contributing to the development of HIV-associated CNS disorders commonly observed in individuals living with HIV. Here, we demonstrate that synapsins, phosphoproteins that are predominantly expressed in neuronal cells and play a vital role in modulating neurotransmitter release at the pre-synaptic terminal, and neuronal differentiation become targets for Tat through autophagy and protein quality control pathways. We demonstrate that the presence of Tat in neurons results in downregulation of BAG3, a co-chaperone for heat shock proteins (Hsp70/Hsc70) that is implicated in protein quality control (PQC) processes by eliminating mis-folded and damaged proteins, and selective macroautophagy. Our results show that treatment of cells with Tat or suppression of BAG3 expression by siRNA in neuronal cells disturbs subcellular distribution of synapsins and synaptotagmin 1 (Syt1) leading to their accumulation in the neuronal soma and along axons in a punctate pattern, rather than being properly distributed at axon-terminals. Further, our results revealed that synapsins partially lost their stability and their removal via lysosomal autophagy was noticeably impaired in cells with low levels of BAG3. The observed impairment of lysosomal autophagy, under this condition, is likely caused by cells losing their ability to process LC3-I to LC3-II, in part due to a decrease in the ATG5 levels upon BAG3 knockdown. These observations ascribe a new function for BAG3 in controlling synaptic communications and illuminate a new downstream target for Tat to elicit its pathogenic effect in impacting neuronal cell function and behavior.

Indexed as

HomeostasisAdaptor Proteins, Signal TransducingAnimalsApoptosis Regulatory ProteinsAutophagyAutophagy-Related Protein 5Cells, CulturedDown-RegulationLysosomesMice, TransgenicModels, BiologicalNeuronsOxidative StressProtein AggregatesProtein BindingRatsAdaptor Proteins, Signal TransducingApoptosis Regulatory ProteinsAutophagy-Related Protein 5BAG3 protein, ratProtein AggregatesRNA, MessengerSynapsinstat Gene Products, Human Immunodeficiency Virus

Identifiers

PMID31209204
PMCPMC6572798
OpenAlexW2951227659

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.